» Articles » PMID: 39134444

Testing a Persuasive Health Communication Intervention (PHCI) for Emergency Department Patients Who Declined Rapid HIV/HCV Screening: a Randomised Controlled Trial Study Protocol

Overview
Journal BMJ Open
Specialty General Medicine
Date 2024 Aug 12
PMID 39134444
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Previous studies have shown that substantial percentages of emergency department (ED) patients in the USA recommended for HIV or hepatitis C (HCV) decline testing. Evidence-based and cost-effective interventions to improve HIV/HCV testing uptake are needed, particularly for people who inject drugs (PWIDs) (currently or formerly), who comprise a group at higher risk for these infections. We developed a brief persuasive health communication intervention (PHCI) designed to convince ED patients who had declined HIV/HCV testing to agree to be tested. In this investigation, we will determine if the PHCI is more efficacious in convincing ED patients to be tested for HIV/HCV when delivered by a video or in person, and whether efficacy is similar among individuals who currently, previously or never injected drugs.

Methods And Analysis: We will conduct a multisite, randomised controlled trial comparing PHCIs delivered by video versus in person by a health educator to determine which delivery method convinces more ED patients who had declined HIV/HCV testing instead to be tested. We will stratify randomisation by PWID status (current, former or never/non-PWID) to permit analyses comparing the PHCI delivery method by injection-drug use history. We will also perform a cost-effectiveness analysis of the interventions compared with current practice, examining the incremental cost-effectiveness ratio between the two interventions for the ED population overall and within individual strata of PWID. As an exploratory analysis, we will assess if a PHCI video with captions confers increased or decreased acceptance of HIV/HCV testing, as compared with a PHCI video without captions.

Ethics And Dissemination: The study protocol has been approved by the institutional review board of the Icahn School of Medicine. The results will be disseminated at international conferences and in peer-reviewed publications.

Trial Registration Number: NCT05968573.

References
1.
Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332. PMC: 2844940. DOI: 10.1136/bmj.c332. View

2.
Wu G, Zhou A, Kwon S . Integrating hepatitis C virus screening of baby boomers at a community hospital emergency department. J Viral Hepat. 2022; 29(4):263-270. DOI: 10.1111/jvh.13654. View

3.
Merchant R, Baird J, Liu T, Taylor L, Montague B, Nirenberg T . Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population. Acad Emerg Med. 2014; 21(7):752-67. PMC: 4135533. DOI: 10.1111/acem.12419. View

4.
Williams J, Vickerman P, Douthwaite S, Nebbia G, Hunter L, Wong T . An Economic Evaluation of the Cost-Effectiveness of Opt-Out Hepatitis B and Hepatitis C Testing in an Emergency Department Setting in the United Kingdom. Value Health. 2020; 23(8):1003-1011. DOI: 10.1016/j.jval.2020.03.014. View

5.
Mendlowitz A, Naimark D, Wong W, Capraru C, Feld J, Isaranuwatchai W . The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluation. Liver Int. 2020; 40(6):1282-1291. DOI: 10.1111/liv.14458. View